Drug Development Consulting BidCo ApS — Credit Rating and Financial Key Figures

Drug Development Consulting BidCo ApS (CVR number: 42287067) is a company from ALBERTSLUND. The company recorded a gross profit of 2320 kDKK in 2023. The operating profit was -622 kDKK, while net earnings were -9381 kDKK. The profitability of the company measured by Return on Assets (ROA) was -5.3 %, which can be considered poor and Return on Equity (ROE) was -13.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 58.2 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Drug Development Consulting BidCo ApS's liquidity measured by quick ratio was 1.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.